Mirae Asset Global Investments Co. Ltd. lowered its holdings in Waters Co. (NYSE:WAT – Free Report) by 3.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,019 shares of the medical instruments supplier’s stock after selling 832 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Waters were worth $6,818,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of WAT. U.S. Capital Wealth Advisors LLC acquired a new position in shares of Waters during the fourth quarter valued at about $49,000. Itau Unibanco Holding S.A. boosted its stake in Waters by 22.3% during the 4th quarter. Itau Unibanco Holding S.A. now owns 181 shares of the medical instruments supplier’s stock valued at $62,000 after purchasing an additional 33 shares during the last quarter. Park Place Capital Corp bought a new stake in Waters during the 1st quarter worth approximately $65,000. Ancora Advisors LLC bought a new stake in Waters during the 4th quarter worth approximately $77,000. Finally, CI Investments Inc. raised its stake in shares of Waters by 52.7% in the fourth quarter. CI Investments Inc. now owns 252 shares of the medical instruments supplier’s stock worth $86,000 after purchasing an additional 87 shares during the last quarter. Institutional investors own 90.09% of the company’s stock.
Analysts Set New Price Targets
Several brokerages recently issued reports on WAT. Bank of America decreased their price target on Waters from $350.00 to $315.00 in a report on Wednesday, May 10th. Wells Fargo & Company reduced their target price on shares of Waters from $345.00 to $305.00 in a research note on Wednesday, May 10th. StockNews.com lowered shares of Waters from a “buy” rating to a “hold” rating in a research report on Friday, May 12th. Robert W. Baird reduced their price objective on shares of Waters from $345.00 to $288.00 in a research report on Wednesday, May 10th. Finally, Barclays lifted their target price on shares of Waters from $275.00 to $288.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 3rd. Eight equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $327.60.
Insider Buying and Selling
In other Waters news, Director Christopher A. Kuebler sold 4,000 shares of the company’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $291.48, for a total transaction of $1,165,920.00. Following the sale, the director now directly owns 14,382 shares of the company’s stock, valued at $4,192,065.36. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.77% of the stock is currently owned by insiders.
Waters Trading Up 2.4 %
Shares of WAT stock opened at $296.73 on Wednesday. The company has a quick ratio of 1.41, a current ratio of 2.08 and a debt-to-equity ratio of 3.35. The firm has a market cap of $17.54 billion, a P/E ratio of 26.17, a PEG ratio of 3.49 and a beta of 0.86. The company has a 50 day moving average of $268.69 and a 200-day moving average of $293.22. Waters Co. has a 12-month low of $248.18 and a 12-month high of $353.70.
Waters (NYSE:WAT – Get Free Report) last released its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.59 by $0.21. The business had revenue of $740.58 million during the quarter, compared to the consensus estimate of $733.51 million. Waters had a return on equity of 124.03% and a net margin of 22.54%. Sell-side analysts anticipate that Waters Co. will post 12.24 earnings per share for the current year.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More
- Five stocks we like better than Waters
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 5 Best Fintech Stocks to Buy Now
- How to Use the MarketBeat Stock Split Calculator
- UPS Slipping To More Attractive Levels On Weak OutlookÂ
- Retail Stocks Investing, Explained
- More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
